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With the demonstration of their trypanocidal action by Lourie and Yorke in
1939 (1), a group of aromatic diamidines, notably stilbamidine (4 4'-stilbenedi-
carboxamidine), propamidine (p , p'-trimethy1enedibenamidine) and pentami-
dine (p p'-pentamethylenedibenzamidine) has found a wide use in the treatment
of trypanosomiasis. Subsequent studies revealed that these compounds possess
as well activity against other protozoans as babesias and leishmanias, bacteria
and fungi. Their development was recently reviewed by Schoenbach and
Greenspan (2).
Propamidine was found by Fuller (3) and Thrower et al (4) to be active in
vitro against gram positive cocci, although much less than against trypanosomes.
It possessed in vitro bacteriostatic and chemotherapeutic activity in mice against
Glostridium welchii, Clostridium oedematiens and Glostridium septicemie (5) in
comparable order as the sulfonamides. Clinical trials using propamidine in the
treatment of infected wounds and burns were successful, comparing favorably
with results obtained from the use of sulfonamide drugs (4, 6, 7, 8). Elson (9)
in 1945 re-investigated the antimicrobial action of propamidine and included a
number of pathogenic fungi as test organisms. His findings revealed striking
results in high dilutions against Trichophyton sulfureum, Aehorion schoenleinii,
Sporotrichum schencki and Blastomyces dermatitidis. Seabury and Artis (10)
in their study of the susceptibility of Histoplasma capsulatum to therapeutic
agents found that this organism was sensitive to stilbamidine in a dilution of
10 mg. %. More recently, Snapper et al (11) confirmed the sensitivity of Blasto-
myces dermatitidis and Histo plasma capsulatum, both in their mycelial and yeast
phases, to dilutions of a few micrograms of stilbamidine or of 2-hydroxystilbami-
dine per ml. of medium. The 2-hydroxystilbamidine was recommended by the
authors on account of the absence of toxic neuropathy, especially of the tn-
geminal nerve, as encountered with stilbamidine administration. Still further
confirmatory evidences were reported as to the fungistatic action of stilbamidine
against Blastomyces dermatitidis (12).
These in vitro studies were followed by in vivo experiments and clinical trials
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on cases of mycoses. The only study so far reported using experimental animals
is that of Heilman (13) wherein he obtained definite suppression by stilbamidine
of pulmonary infection of mice with Blastomyces derinatitidis given intravenously.
Infections of the brain among these mice, however, were not controlled. Seabury
(14) in his two cases of histoplasmosis treated with stilbamidine reported at most
only initial and temporary improvement with no significant effect on the course
of the disease. No favorable response was also obtained in three cases of crypto-
coccosis given stilbamidine (15). It is in the treatment of both cutaneous and
systemic North American blastomycosis that encouraging results were en-
countered (ii, 12, 15, 16, 17, 18). A patient with actinomycosis resistant to
penicillin and sulfadiazine responded promptly to the administration of
stilbamidine (19).
Diethylstilbestrol (4, 4'-dihydroxy-a, a'-diethylstilbene) followed a different
course of development. In 1938, Dodds et al (20) during the course of their study
of estrogenic compounds became impressed with the extreme potency of diethyl-
stilbestrol and it has found a wide clinical application as an estrogen since then.
Beside this better known estrogenic property, diethylstilbestrol has in addition
remarkable in vitro antibacterial activity against gram positive organisms in the
order of 1:50,000 to 1:500,000 as the minimum effective concentration (21, 22,
23). Faulkner (24) reported bactericidal activity against Mycobacterium tubercu-
losis in a range of 1:5,000 to 1:100,000 minimum lethal concentration. A single
dose of 40—50 rat units of stilbestrol was found by Foley and Aycock (25) to
render mice highly resistant to a dose of mouse virulent hemolytic streptococci
which regularly killed normal mice of the same sex and age. The estrogen was
given 48 hours before the mice were infected with the streptococci and the
authors suggested that the protection was due to a stilbestrol-induced factor
which interfered with the spread of the organisms.
Investigations on the in vitro antifungal activity of diethyistilbestrol are
relatively meager. Harder (26) in studying the effects of diethyistilbestrol on
superficial mycotic infections supplemented his clinical findings with in vitro
experiments wherein the lowest inhibiting concentrations were determined as
1:20,000 for Microsporum gypseum and Trichophyton schoenleinii; 1:40,000
for Micros porum audouini, Micros porum canis and Trichophyton mentagrophytes;
1:60,000 for Trichophyton rubum and Epidermophyton floccosum; and 1:100,000
for Blastomyces dermatitidis and Histoplasma capsulatum. Reiss (27) included
diethyistilbestrol in a group of sex hormones he was testing for possible fungicidal
effects and found it effective in retarding the growth of Trichophyton rubrum,
but not of Trichophyton qypseum. He expanded this study using diethyistilbestrol
and 11 steroid hormones with 14 pathogenic fungi as test organisms and still
found diethylstilbestrol most effective, particularly against Microsporum audouini,
Epidermophyton inguinale, Histo plasma capsulatum and Actinomyces transyl-
vanensis (28). In another investigation, diethyistilbestrol was reported by
Heinemann (29) to possess fungistatic activity at levels of 1:40,000 to 1:80,000
dilution against Trichophyton purpureum, Trichophyton sulfureum, Epidermo-
phyton floccosum, Microsporum andouini, Achorion schoenleinii and Coccidioides
immitis.
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Based on the observation that tinea capitis exhibited spontaneous involution
at puberty, diethylstilbestrol was tried on account of its hormonal effects in the
treatment of tinea capitis locally and/or orally with variable results. Favorable
responses were obtained by Poth and Kaliski (30), by Law (31) and by Harder
(26), but the species of the causative organisms were not determined for the
individual cases in these studies. Failures were reported by Lewis, Hopper and
Reiss (32), by Felsher (33) and by Dobes (34). Micros porum audouini was
isolated from most of the cases of tinea capitis used in the latter investigations.
As regards the use of diethyistilbestrol in deep mycosis, Curtis and Harrell (12),
noting the similarity of the chemical structures of diethylstilbestrol and stilbami-
dine, reported the first two cases of cutaneous North American blastomycosis
with regression under diethylstilbestrol therapy.
Other hormones were found to have certain action on pathogenic fungi.
The first studies along these lines were reported by Hruszek (35) who obtained
definite inhibition of growth of Micros porum audouini, Trichophylon gypscum
and Trichophyton schocnleinii by prolan extracted from the anterior pituitary
gland and, to a lesser extent, by folliculin. Of the hormones tested by Reiss (27)
methyltestosterone had a more definite fungistatic effect on the growth of
Trichophyton purpurcum and Trichophyton qypseum than alpha-estradiol and
desoxycorticosterone. When topically applied, it \vas also more effective than
aipha-estradiol against experimental Trichophyton purpurcum infection in cas-
trated rabbits (36). Both were, however, ineffectual when given by injections.
More recently, Nekam and Polgar (37) confirmed the fungistatic activity of sex
hormones containing the sterol radical as well as of the stilbene derivatives.
Methyltestosterone was included in the present study because of the above
findings and because of the more favorable results obtained with it during
preliminary screening fungistatie tests of different steroid hormones done in this
laboratory. Isonicotinic acid hydrazide was also tested because of the present
interest on its bacteriostatic activity against Mycobactcriunz tuberculosis and the
observation that it may possess some slight antifungal properties (38).
In view of the results of these scattered studies on the stilbene derivatives,
it seemed worthwhile to investigate further in detail the comparative fungistatic
spectra of these compounds.
METHODS
Stock solutions of known concentrations of each compound tested were prepared first in
appropriate solvents. Distilled water was used for dissolving stilbamidine, propamidine,
pentamidine and isonicotinic acid hydrazide (eotinazin, Pfizer) and acetone for diethyl-
stilbestrol and methyltestosterone. Calculated amounts of the stock solutions were incor-
porated into Sabouraud's dextrose agar and blood agar that had been autoelaved and
cooled to about 50°C. The addition was made with sufficient shaking to insure uniformity
in solution. The resulting final dilutions of each compound in the agar medium were in a
series of 1 mg./ml. medium, 0.1 mg/mi., 0.01 mg./ml. and0.001 mg/mi. Itwasfound neces-
sary to extend these dilutions in some instances to 0.1 mierogram/ml. medium, 0.01 micro-
gram/mi. and 0.001 microgram/mi. These were set up in tube slants.
Stilbamidine, propamidine and pentamidine are used in this report in terms of their
isethionate salts.
Young vigorous colonies of each test organism were obtained and as uniform suspensions
152 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
as possible of the organisms in physiological salt solution were made. Uniformity of suspen-
sion was easily achieved with the yeast forms, but with certain difficulties among the
filamentous colonies. One tenth ml. of each of these suspensions were inoculated into the
prepared slants.
The final set-up was made such that each test organism which numbered 26 was tested
against the serial dilutions of each of the six compounds used in the investigation. All the
experiments were done in duplicates and properly controlled. Controls for the compounds
dissolved in acetone were set up by adding 1.0% of acetone to Sabouraud's dextrose agar
slants which was the amount used in making up the serial dilutions.
The cultures were left at room temperature and observed closely every week up to six
weeks, even up to twelve weeks for very slowly growing cultures. In the eases of the di-
morphic species of Blastomyces dermatitidis, Blastomyces braziliensis and Histo plasma
capsulatum, similar experiments were performed using blood agar dextrose slants incubated
at 37°C.
Results that revealed promising inhibitions were checked with repeat experiments.
Experiments using infected clinical materials were also performed. Instead of suspen-
sions of cultures of the organisms, positive KOH skin scrapings and fluorescing hairs to
Wood's light were used as inoculants on slants of serial dilutions of diethylstilbestrol as
set up in the previous experiments in triplicates. These were similarly controlled and
observed. The skin scrapings were taken from a case of tinea corporis which revealed
growth of Trichophyton mentagrophytes. The hairs were obtained from three cases of
tinea capitis caused by Microsporuni audouini.
RESULTS AND DISCUSSION
In view of the possible influence of changes in pH of the medium brought about
by the addition of the compounds, the pH of representative samples of each
medium was determined. The greatest change in pH was found to be pH 0.2.
This was considered not big enough of a change to significantly affect the growth
of the fungi tested inasmuch as these different species are proven to possess the
ability to grow in a remarkably wide range of pH.
Results obtained are presented in Table I. It is to be noted that of the com-
pounds tested, diethylstilbestrol had the widest range and greatest activity
against the species used as test organisms. It was effective at dilutions of 1
microgram/mi. medium against Histo plasma capsulatum, Blastomyces dermatitidis,
Blastomyces braziliensis and Trichophyton ferrugineum and at a level of 10
microgram/mi. against Trichophyton rubrum, Trichophyton schoenleinii, Tn-
chop yton violaceum, Trichophyton tonsurans, Epidermophyton floccosum, Nocardia
asteroides and Coccidioides immitis. Its in vitro efficacy against Coccidioides
immitis seems to warrant further investigations.
Most of the strains were inhibited by stilbamidine, propamidine, and pentami-
dine at a concentration of 1 mg./ml. medium. Stilbamidine showed activity in
lower concentrations only against Hormodendrum pedrosoi and Blastomyces
dermatitidis and pentamidine only against Hormodendrum pedrosoi and Sporo-
tnichum schenchi. Propamidine had a wider spectrum, being effective at higher
diiutions against Trichophyton ferrugineum, Cladosporium wernecki, Hormoden-
drum pedrosoi, Phialophora verrucosa, Sporotrichum schencki, Blastomyces derma-
titidis, Blastomyces brazilien,sis, and Coccidioides immitis.
Two strains of Blastomyces dermatitidis were examined. One was freshly
isolated from a case of pulmonary biastomycosis with dissemination to the
subcutaneous tissue and skin. The other presented an opportunity for sensitivity
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TABLE I
The lowest effective concentrations in mg. of compound tested per ml. medium against fungi
STILBAMI- P1IOPAMI- PENTAMS- I DIETLYL- METDYLTES-. ISONICO-
DINE DINE DINE STSLEEITEOL TOITEEONE TINIC ACID
Trichophyton mentagrophytes... 1.0 >1.0 >1.0 0.1 >1.0 >1.0
Trichophyton rubrum 1.0 1.0 1.0 0.01 0.1 >1.0
Trichophyton schoenleini 1.0 1.0 1.0 0.01 >1.0 >1.0
Trichophyton violaceum 1.0 1.0 1.0 0.01 0.1 >1.0
Trichophyton ferrugineum 1.0 0.1 1.0 0.001 0.1 >1.0
Trichophyton tonsurans 1.0 1.0 1.0 0.01 0.1 >1.0
Microsporumgypseum 1.0 1.0 1.0 0.1 >1.0 >1.0
Microsporumaudouini 1.0 1.0 1.0 0.1 >1.0 >1.0
Microsporumcanis 1.0 1.0 1.0 0.1 >1.0 >1.0
Epidevmophytonfloccosum 1.0 1.0 1.0 0.01 0.1 >1.0
Cladosporiumwernecki 1.0 0.1 1.0 0.1 >1.0 >1.0
ilormodendrum pedrosoi 0.01 0.1 0.1 >1.0 >1.0 >1.0
Phialophora.verrucosa 1.0 0.1 1.0 >1.0 >1.0 >1.0
Monosporium apiospermum 1.0 1.0 1.0 0.1 >1.0 >1.0
Nocardiaasteroides 1.0 1.0 1.0 0.01 >1.0 >1.0
Candida albicans >1.0 >1.0 >1.0 >1.0 >1.0 >1.0
Cryptococeusneoformans 1.0 >1.0 >1.0 >1.0 >1.0 >1.0
Sporotrichumschencki 1.0 0.01 0.001 1.0 >1.0 >1.0
Blastomyces dermatitidis*
(Reaney strain) Room temp... 0.1 0.1 1.0 0.001 >1.0 >1.0
Blastomyces dermatitidis5
(Heaney strain) 37°C 0.01 0.01 1.0 0.01 >1.0 >1.0
Blastomyces dermatitidist
(Gordon strain) Room temp... 0.1
Blastomyces dermatitidist
(Gordon strain) 37°C 0.1
Blastomyces dermatitidist
(Gordon strain) Room temp... 1.0 0.1 1.0 0.01 1.0 >1.0
Blastomyces braziliensis
Room temp 1.0 0.01 1.0 0.001 0.1 >1.0
Blastomyces braziliensis 37°C... 1.0 0.1 0.1 0.01 0.1 >1.0
Histoplasma eapsulatum Room
temp 1.0 1.0 1.0 0.001 0.1 >1.0
Histoplasma capsulatum 37°C... 0.1 0.01 1.0 0.1 0.1 >1.0
Coccidioidesimmitis 1.0 0.1 1.0 0.01 >1.0 >1.0
Alternariasp 0.1 0.01 1.0 >1.0 >1.0 >1.0
Penicillium sp 1.0 >1.0 >1.0 >1.0 >1.0 >1.0
Aspergillusniger 1.0 1.0 >1.0 i >1.0 >1.0 >1.0
* This strain was freshly isolated from the sputum of an active untreated case of systemic
blastomycosis.
t This original isolate was obtained from a ease of cutaneous and systemic blastomycosis
before stilbamidine therapy.
1 This was isolated from a recurrent subcutaneous abscess from the same patient after
having had two courses of stilbamidine with remissions.
tests before and after administration of stilbamidine. This was originally isolated
from a patient who had systemic and cutaneous blastomycosis. The second
isolate was obtained ten months later, after the patient had had essentially two
courses of stilbamidine with remissions and recurrences. The first course was
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divided into 100 mg. of stilbamidine given intravenously daily for 6 days in
August, 1951; 150 mg. for 12 days in September, 1951; and 150 mg. for 10 days
in October, 1951. With these, the patient improved remarkably and was dis-
charged. However, he returned two months later with recurrent lesions and was
given the second course of 150 mg. stilbamidine daily for 22 days in January,
1952. Again, he responded favorably but only to return three months later with
another recurrence at which time the second isolate of this strain was taken.
This second isolate was completely inhibited by stilbamidine only at a concentra-
tion of 1 mg./ml. medium whereas the original isolate taken before any stilbami-
dine therapy was inhibited at a concentration of 0.1 mg./ml. This, plus the
clinical recurrences, may be suggestive of the acquisition of resistance to
stilbamidine by the organism.
Methyltestosterone revealed a certain amount of fungistasis against some
dermatophytes, Blastomyces der;natitidis, Blastomyces braziliensis and Histo-
plasma capsulatum.
Isonicotinic acid hydrazide showed no fungistatic activity at the range of
concentrations used.
The nonpathogenic species—aiternaria, penicilhum and aspergillus—were re-
sistant, except for some sensitivity of alternaria to stilbamidine and propamidine.
Among the pathogenic species studied, Candida albicans, Cry ptoccccus neofor-
mans and Nocardia asteroides seem to be more resistant.
The lowest concentration of diethylstilbestrol where no growth appeared after
implantation with skin scrapings from a KOH positive case of tinea corporis
infection by Trichophyton mentagrophytes was 0.1 mg/mi. medium. The fluo-
rescent hairs from three cases of tinea capitis caused by Micros porum andouini
did not reveal growth at the lowest concentrations of 0.1 mg./ml. in one case
and 0.01 mg/mi. in two cases. These inhibiting concentrations are more or less
in the same order as those obtained using subcultures of the organisms. All
controls in these experiments were positive.
It seems worthwhile to extend these comparative screening tests for fungistatic
activity to other stilbene derivatives and related compounds as had been notably
done regarding their bacteriostatic and bactericidal properties. It is unfortunate
that these investigations were practically cut short with the eminently successful
use of the sulfonamide derivatives and the antibiotics in bacterial infections,
but results already suggested that quite a number oi these stilbenes were active
against bacteria in vitro. Brownlee et al (21) and Faulkner (23) found 4-hydroxy-
a b-diethylstilbene to be the most active compound in their series which also
included diethylstilbestrol. Similarly, fungistatic activity may also not be limited
to the four related compounds presently studied. The search for other stilbenes
that may show equal, if not greater, fungistatic activity than that shown by
diethyistilbestrol is more desirable in view of the probability that the potent
estrogenic property of diethylstilbestrol may become a definite limitation in its
use clinically as a chemotherapeutic agent. Such a compound possessing high
fungistatic without estrogenic activity may be existent. Curtis and Harrell (12)
suggested that the clinical effects of the stilbenes on mycosis were chemothera-
peutic and not simply hormonal. The degree of bactericidal properties of these
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Compounds has been shown to be uncorrelated with their estrogenic abilities
(21, 22, 23, 39, 40).
SUMMARY
1. Using the Sabouraud's agar dilution method, the fungistatic spectra of
stilbamidine, propamidine, pentamidine, diethyistilbestrol, methyltestosteroae
aad isonicotinic acid hydrazide were determined against 22 species of pathogenic
and 3 species of nonpathogenic fungi.
2. The order of these compounds as regards their in vitro fungistatic activity
was as follows: diethylstilbestrol, propamidine, stilbamidine, pentamidine and
methyltestosterone. Isonicotinic acid hydrazide showed no demonstrable
fungistasis.
3. The sensitive strains of pathogenic fungi included a number causing
systemic mycoses, as Btastomyces dermatitidis, Blastornyces braziliensis, Histo-
plasma capsulatum, iSporotrichum schencki and Coccidioides immitis.
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